发明名称 |
PYRIDINE AND PYRAZINE DERIVATIVES AS PROTEIN KINASE MODULATORS |
摘要 |
597551 Disclosed herein is a compound of formula (I), wherein the variables are defined in the specification; a pharmaceutical composition comprising said compound; and the use of said compound in the treatment of a disease or condition mediated by CDK9, such as cancer, cardiac hypotrophy, HIV, and inflammatory diseases. Embodiments of the compound include the following: 3,5'-dichloro-N2'-(trans-4-(((R)-2,2-dimethy-1-1,3-dioxolan-4-yl)methyl)aminocyclohexyl)-N6-((tetrahydro-2H-pyran-4-yl)methyl)-2,4'-bipyridine-2',6-diamine, and trans-4-(5-chloro-4-(6-((tetrahydro-2H-pyran-3-yl)methyl)aminopyrazin-2-yl)pyridin-2-yl-amino)cyclohexanol. |
申请公布号 |
NZ597551(A) |
申请公布日期 |
2013.10.25 |
申请号 |
NZ20100597551 |
申请日期 |
2010.07.28 |
申请人 |
NOVARTIS AG |
发明人 |
BARSANTI, PAUL A;HU, CHENG;JIN, JEFF;KEYES, ROBERT;KUCEJKO, ROBERT;LIN, XIAODONG;PAN, YUE;PFISTER, KEITH B;SENDZIK, MARTIN;SUTTON, JAMES;WAN, LIFENG |
分类号 |
C07D213/74;A61K31/444;A61K31/497;A61K31/506;A61P29/00;A61P35/00;C07D241/20;C07D401/04;C07D401/12 |
主分类号 |
C07D213/74 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|